Michael Adam
2011
In 2011, Michael Adam earned a total compensation of $2.8M as Former Senior Vice President and Chief Operating Officer at Heron Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $109,200 |
|---|---|
| Option Awards | $2,443,005 |
| Salary | $216,000 |
| Other | $5,040 |
| Total | $2,773,245 |
Adam received $2.4M in option awards, accounting for 88% of the total pay in 2011.
Adam also received $109.2K in non-equity incentive plan, $216K in salary and $5K in other compensation.
Rankings
In 2011, Michael Adam's compensation ranked 2,339th out of 10,747 executives tracked by ExecPay. In other words, Adam earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,339 out of 10,747 | 78th |
Division Manufacturing | 841 out of 3,960 | 79th |
Major group Chemicals And Allied Products | 181 out of 1,038 | 83rd |
Industry group Drugs | 103 out of 786 | 87th |
Industry Pharmaceutical Preparations | 86 out of 571 | 85th |
Source: SEC filing on May 9, 2013.
Adam's colleagues
We found one more compensation record of an executive who worked with Michael Adam at Heron Therapeutics in 2011.
2011
John Whelan
Heron Therapeutics